Innoviva (INVA) Property, Plant & Equipment (Net) Growth (5y) (2015 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Innoviva | 1.60 Bn | 992.84 Mn | 75.83 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 145.54% |
| Dec 31, 2025 | 123.31% |
| Sep 30, 2025 | 115.37% |
| Jun 30, 2025 | 64.89% |
| Mar 31, 2025 | 62.98% |
| Dec 31, 2024 | 73.18% |
| Sep 30, 2024 | 86.67% |
| Jun 30, 2024 | 25.71% |
| Mar 31, 2024 | 16.97% |
| Dec 31, 2023 | 24.73% |
| Sep 30, 2023 | 15.85% |
| Jun 30, 2023 | -2.74% |
| Mar 31, 2023 | -1.79% |
| Dec 31, 2022 | -4.05% |
| Sep 30, 2022 | -7.90% |
| Jun 30, 2022 | -9.44% |
| Mar 31, 2022 | -10.25% |
| Dec 31, 2021 | -49.57% |
| Sep 30, 2021 | -47.64% |
| Jun 30, 2021 | -35.78% |
| Mar 31, 2021 | -34.09% |
| Dec 31, 2020 | -33.85% |
| Sep 30, 2020 | -33.19% |
| Jun 30, 2020 | -33.10% |
| Mar 31, 2020 | -32.65% |
| Dec 31, 2019 | -36.67% |
| Sep 30, 2019 | -17.81% |
| Mar 31, 2019 | -56.71% |
| Dec 31, 2018 | -56.47% |
| Sep 30, 2018 | -54.18% |
| Jun 30, 2018 | -53.97% |
| Mar 31, 2018 | -53.45% |
| Dec 31, 2017 | -53.04% |
| Sep 30, 2017 | -51.81% |
| Jun 30, 2017 | -50.43% |
| Mar 31, 2017 | -49.57% |
| Dec 31, 2016 | -48.71% |
| Sep 30, 2016 | -48.19% |
| Jun 30, 2016 | -55.82% |
| Dec 31, 2015 | -53.55% |